España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Anika Therapeutics
ANIK
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$17.06
-0.22
-1.27%
At close: -
$17.06
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Anika Therapeutics (ANIK) Forecast
News
Earnings
Anika Therapeutics (ANIK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Anika Therapeutics (NASDAQ:ANIK) Stock
Anika Therapeutics Stock (NASDAQ: ANIK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 01, 2024
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Thursday, October 31, 2024
Anika Therapeutics shares are trading lower a...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Anika Closes Divestiture Of Its Arthrosurface...
Benzinga Newsdesk
Anika Therapeutics Q3 2024 Adj EPS $(0.25) Mi...
Benzinga Newsdesk
Wednesday, October 30, 2024
What's Next: Anika Therapeutics's Earnings Preview
Benzinga Insights
Tuesday, October 22, 2024
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Friday, August 09, 2024
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Thursday, August 08, 2024
Anika Therapeutics Affirms FY2024 Sales Guida...
Benzinga Newsdesk
Anika Therapeutics Q2 2024 Adj. EPS $0.17 Bea...
Benzinga Newsdesk
Thursday, July 11, 2024
Anika Therapeutics Announces Full Market Rele...
Benzinga Newsdesk
Wednesday, May 29, 2024
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
Benzinga Insights
Stephens & Co. Reiterates Equal-Weight on Ani...
Benzinga Newsdesk
Tuesday, May 28, 2024
Anika Authorizes $40M Share Repurchase Progra...
Benzinga Newsdesk
Anika Enters Into Cooperation Agreement With ...
Benzinga Newsdesk
Thursday, May 09, 2024
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Wednesday, May 08, 2024
Anika Says Cost Reduction Initiatives Complet...
Benzinga Newsdesk
Anika Announces Steve Griffin Appointed To CF...
Benzinga Newsdesk
Anika Therapeutics Q1 2024 Adj EPS $0.09 Beat...
Benzinga Newsdesk
Thursday, March 14, 2024
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Stephens & Co. Reiterates Equal-Weight on Ani...
Benzinga Newsdesk
Wednesday, March 13, 2024
Anika Therapeutics: Q4 Earnings Insights
Benzinga Insights
Anika Therapeutics Q4 2023 Adj EPS $0.05 Beat...
Benzinga Newsdesk
Anika Therapeutics Sees FY24 Revenue $168M-$1...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Tuesday, March 12, 2024
Earnings Outlook For Anika Therapeutics
Benzinga Insights
Wednesday, January 03, 2024
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Tuesday, November 28, 2023
Anika Announces First Surgeries Performed Usi...
Benzinga Newsdesk
Friday, November 03, 2023
Barrington Research Maintains Outperform on A...
Benzinga Newsdesk
Thursday, November 02, 2023
Anika Therapeutics Sees FY23 Revenue $164M-$1...
Benzinga Newsdesk
Anika Therapeutics Q3 Sales $41.47M Beat $38....
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Tuesday, September 05, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 14, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
Benzinga Insights
Barrington Research Upgrades Anika Therapeuti...
Benzinga Newsdesk
Thursday, August 10, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Stephens & Co. Maintains Equal-Weight on Anik...
Benzinga Newsdesk
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, August 08, 2023
Anika Therapeutics Q2 Adj EPS $0.06 Beats $(0...
Benzinga Newsdesk
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, May 31, 2023
Stephens & Co. Reiterates Equal-Weight on Ani...
Benzinga Newsdesk
Tuesday, May 30, 2023
Anika Completes Enrollment in Hyalofast U.S. ...
Benzinga Newsdesk
Tuesday, May 09, 2023
Recap: Anika Therapeutics Q1 Earnings
Benzinga Insights
Anika Therapeutics Sees FY23 Revenue $158M-$1...
Benzinga Newsdesk
Anika Therapeutics Q1 EPS $(0.36) Misses $(0....
Benzinga Newsdesk
Earnings Scheduled For May 9, 2023
Benzinga Insights
Friday, April 14, 2023
Stephens & Co. Reiterates Equal-Weight on Ani...
Benzinga Newsdesk
Thursday, April 13, 2023
Anika Enters Into Cooperation Agreement With ...
Michael Horton
Show More
